schizandrer a has been researched along with Injury, Ischemia-Reperfusion in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, G; Guo, W; Liu, F; Lu, H; Zhan, Y; Zhang, M; Zheng, N | 1 |
Chen, C; Ding, F; Liang, XM; Shi, YW; Tang, M; Wang, CP; Wang, ZW; Zhang, XC | 1 |
2 other study(ies) available for schizandrer a and Injury, Ischemia-Reperfusion
Article | Year |
---|---|
Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cyclooctanes; Dioxoles; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Humans; Lignans; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Reperfusion Injury; Schisandraceae; Signal Transduction | 2017 |
Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Survival; Cerebral Cortex; Cyclooctanes; Dioxoles; Inflammation; Lignans; Necrosis; Neurons; Neuroprotective Agents; Oxidative Stress; Parietal Lobe; Primary Cell Culture; Rats, Sprague-Dawley; Receptor, Anaphylatoxin C5a; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4 | 2017 |